Clinical Trials Browser

Carcinoma, Renal Cell × sodium-iodide symporter × 30 days × Clear all

NCT07510334 2026-06-05

VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Phase 2 Recruiting

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell